Table of Contents
Definition of Candidiasis
Candidiasis is a fungal infection that is caused by Candida albicans. Candidiasis is an opportunistic infection that has been getting more common in the recent decades due to the introduction of immunosuppression and the growth observed in the populations that are at risk for opportunistic infections. Cancer therapy, organ transplantation, diabetes, and AIDS are common risk factors for candidiasis.
Epidemiology of Candidiasis
Candidiasis is considered as the most common fungal infection in the immunocompromised patient. Candida asymptomatic colonization is found in approximately 50% of the normal population.
Vulvovaginal candidiasis might be the most common form of the disease and is reported in approximately 75% of women in their lifetime.
Patients with HIV are at risk of developing oropharyngeal candidiasis and esophageal candidiasis if they do not get highly active antiretroviral therapy (HAART).
Etiology of Candidiasis
Candidiasis is unlikely to occur in healthy subjects except for vulvovaginal candidiasis which is reported in at least 75% of women in their life-time. In order for a patient to develop candidiasis, he or she need to be immunocompromised.
Accordingly, any patient with liver cirrhosis, systemic collagen disorders, diabetes, genetic disorders that predispose to immunosuppression, cancer patients, patients with rheumatoid arthritis who are receiving chemotherapy and patients receiving radiotherapy are at risk of developing candidiasis. Additionally, AIDS patients and patients with HIV who are not on HAART can develop candidiasis.
Patients who have undergone a recent bone marrow transplantation, solid organ transplantation, or who are severely immunocompromised due to chemotherapy or radiotherapy are at the highest risk of developing systemic and disseminated candidiasis.
Pathophysiology of Candidiasis
Candidiasis is caused by the fungus Candida which is known to infect humans and animals. Interestingly, candida species have been isolated from the hospital equipment such as hospital floors, air-conditioners, and medical devices. This finding explains why candidiasis is common in intensive care unit patients and in patients who undergo complex surgeries.
Candida has several characteristics that allows the fungus to become pathogenic in a susceptible host. On the cell wall, there are certain surface molecules that facilitate cell-to-cell adherence with the host cells. Additionally, candida produces certain proteases that allows for tissue penetration.
For candidiasis to happen, the patient’s natural barrier and immunologic responses need to be impaired. Wounds, burns, catheters and surgical interventions break the mucocutaneous barriers that prevent candida from entering the blood stream. Abnormalities in cell-mediated immunity such as in patients with HIV infection, diabetes or who are on steroids also put the patient at risk of developing systemic candidiasis.
Clinical Presentation of Candidiasis
Depending on the affected site, candidiasis can cause different clinical syndromes and semiology.
Cutaneous candidiasis can present as a generalized disease, intertrigo, candida folliculitis, or nail infection. Patients with generalized cutaneous candidiasis present with wide-spread skin eruption over the abdomen, chest and upper and lower extremities. Maximum pruritus is usually in the genital folds. Such patients are expected to be more immunocompromised when compared to the other types of cutaneous candidiasis.
Intertrigo is defined as a localized skin infection in a skin fold, for example in the axilla, that presents with red rash, pustules, and vesicles. Eventually, a white rim develops over the rash due to the proliferation of candida. Patients with candida folliculitis develop a localized infection of a hair follicle and are usually less immunocompromised than the other patients described above.
Diabetes mellitus is associated with an increased risk of onychomycosis, a fungal nail infection that is caused by candida species. Patients present with nail thickening, pain and redness under the nail, and a tense nail bed that is warm and inflamed. These forms of skin infection can become chronic in patients with hypoparathyroidism, diabetes, autoimmune disorders, and thymomas.
Patients with known history of HIV infection are at risk of developing oropharyngeal candidiasis especially when they are not on HAART. Additionally, diabetics and patients who receive broad-spectrum antibiotics may develop oropharyngeal candidiasis. Such patients present with a sore mouth, burning tongue and white patches over the oral mucosa. Physical examination reveal membranes that are white, erythematous patches on the hard and soft palates, and angular cheilitis.
Esophageal candidiasis is common in patients who are more severely immunocompromised such as patients on chemotherapy and HIV infection. Patients present with dysphagia, chest pain, painful swallowing, and nausea and vomiting. Patients with esophageal candidiasis also have oropharyngeal candidiasis.
Women are at risk of developing vulvovaginal candidiasis, which usually presents with pain, vaginal discharge, dysuria and painful intercourse. This is the most common form of candidiasis that can be identified in healthy subjects without known risk factors. Of such women, if they have intercourse with a male partner, the male partner might develop candida balanitis. Candida balanitis presents as a penile whitish rash that is painful and also associated with dysuria.
Patients with neutropenia and malignancy are at risk of developing systemic candidiasis. Hepatosplenic candidiasis presents in these patients with fever, right upper abdominal pain, and jaundice that is not responsive to wide spectrum antibiotics.
Candidemia is another form of systemic candidiasis that is usually identified in hospitalized patients who develop a fever that is not responsive to antibiotics. Patients have history of prolonged intravenous catheterization and are usually in the intensive care unit.
Disseminated candidiasis is another form of systemic candidiasis in which multiple organs are involved. Similar to candidemia, patients present with a fever that is unresponsive to antibiotic therapy and are usually hospitalized and severely ill.
Diagnostic Work-up for Candidiasis
Similar to different presentations according to the candidiasis syndrome, work-up is usually different from one patient to another.
Patients with cutaneous candidiasis benefit from a wet mount or smear test that is obtained from the skin rash. Microscopic examination shows hyphae and pseudohyphae. Potassium hydroxide smears are also helpful for the demonstration of the pseudohyphae. Cultures of the nail bed in onychomycosis can confirm the diagnosis of candida infection.
Blood cultures are indicated in systemic candidiasis but are usually positive in only 60% of the cases. A faster and more sensitive test has been developed to detect systemic candidiasis with one look for beta-glucan which is a fungal cell wall antigen in the blood sample.
Patients who present with vulvovaginitis due to candidiasis or balanitis benefit from a urine analysis which reveals white blood cells, red blood cells and yeast cells. Urine cultures might be indicated when in doubt.
Patients with known risk factors for esophageal candidiasis need an upper endoscopy study with a biopsy to confirm the diagnosis and initiate treatment. Patients with hepatosplenic candidiasis usually have cholestasis and an elevated alkaline phosphatase.
Imaging studies with upper endoscopy is indicated in patients with esophageal candidiasis. Ultrasonography can show echogenic foci in the liver, intra-abdominal abscess formation, renal abscess and renal fungus balls in patients with hepatosplenic candidiasis.
Patients with disseminated candidiasis benefit from computerized tomography scans to detect hepatosplenic abscesses, renal abscess, or pyelonephritis. Echocardiography is indicated to exclude candida endocarditis in which large valvular vegetation can be identified.
Treatment of Candidiasis
Patients with candidemia or disseminated candidiasis should be prescribed fluconazole. Similar to syndrome-specific work-up and presentation, treatment is also tailored to the specific anatomic site involved in the infection.
Topical ketoconazole, nystatin, clotrimazole or econazole can be used for cutaneous candidiasis that is localized. Patients with nail infections might need drainage of the abscess underneath the nail in addition to oral antifungal treatment with fluconazole. Oral itraconazole has been used successfully in patients with candida onychomycosis.
Patients with oropharyngeal candidiasis might be treated with topical nystatin or amphotericin B. In case there is no response, patients can be prescribed oral fluconazole or itraconazole.
Patients with HIV and oropharyngeal candidiasis should be prescribed a higher dose of fluconazole and should be initiated on HAART. Amphotericin B or caspofungin intravenously with anidulafungin is indicated in HIV patients with candidiasis who do not respond to oral fluconazole.
Patients with esophagitis might have severe pain on swallowing and initial IV fluconazole can be used at first. Once the symptoms improve, patients should take fluconazole for two to three weeks more.
Women with vulvovaginal candidiasis need a single dose of oral fluconazole 150 mg to achieve clinical and microbiological improvement.
Caspogungin, anidulafungin or micafungin is indicated in patients with systemic candidiasis who are also neutropenic due to chemotherapy or hematologic malignancy. Patients with systemic candidiasis usually have a focus of infection such as an intravenous line which needs to be removed.
Patients with hepatosplenic candidiasis need more extensive treatment regimens that involve an induction phase with amphotericin B for two weeks followed by 12 weeks of oral fluconazole.
Patients who develop intraabdominal abscesses might need a surgical intervention to drain such abscesses in order for antifungal therapy to be effective. Patients who develop candida endocarditis always need a valvular replacement surgery.
Bone debridement is indicated in patients with candida osteomyelitis. Patients with prosthetic joints who develop a candida infection of the prosthetic joint might need the prosthesis to be removed.